{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:55:15Z","timestamp":1792428915510,"version":"4.5.0"},"reference-count":101,"publisher":"Impact Journals, LLC","issue":"32","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,8,9]]},"DOI":"10.18632\/oncotarget.9683","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T22:53:13Z","timestamp":1464735193000},"page":"52584-52596","source":"Crossref","is-referenced-by-count":56,"title":["Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment"],"prefix":"10.18632","volume":"7","author":[{"given":"Piotr","family":"Czapiewski","sequence":"first","affiliation":[{"name":"Department of Pathomorphology, Medical University of Gda\u0144sk, Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Kunc","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Medical University of Gda\u0144sk, Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Haybaeck","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, Institute of Pathology, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,5,31]]},"reference":[{"key":"1","article-title":"Tumours of the Nasal Cavity and paranasal sinuses","author":"Sidransky","year":"2005","journal-title":"Pathol Genet Head Neck Tumours"},{"key":"2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.neures.2010.12.006","article-title":"Immunohistochemical detection of olfactory-specific sensory transduction proteins in olfactory neuroblastoma","volume":"69","author":"Otaki","year":"2011","journal-title":"Neurosci Res"},{"key":"3","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.4238\/2013.September.10.4","article-title":"Odorant receptor genes are expressed in olfactory neuroblastoma","volume":"12","author":"Malnic","year":"2013","journal-title":"Genet Mol Res"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1111\/vco.12102","article-title":"Of mice and men: olfactory neuroblastoma among animals and humans","author":"Biernat","year":"2014","journal-title":"Vet Comp Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuchi.2014.03.007","article-title":"Treatment of esthesioneuroblastomas","volume":"60","author":"Meling","year":"2014","journal-title":"Neurochirurgie"},{"key":"6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0028-1096195","article-title":"Esthesioneuroblastoma: Results and Outcomes of a Single Institution's Experience","volume":"19","author":"Marentette","year":"2009","journal-title":"Skull Base"},{"key":"7","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1007\/s00405-014-3035-1","article-title":"Critical analysis of recurrences of esthesioneuroblastomas: can we prevent them?","volume":"271","author":"Herman","year":"2014","journal-title":"Eur Arch Oto-Rhino-Laryngology"},{"key":"8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MPH.0000000000000095","article-title":"Esthesioneuroblastoma in children and adolescent: experience on 11 cases with literature review","volume":"36","author":"Oberlin","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11060-008-9645-y","article-title":"Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma","volume":"90","author":"Buckner","year":"2008","journal-title":"J Neurooncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3171\/2010.2.JNS091897","article-title":"Posttreatment prognosis of patients with esthesioneuroblastoma","volume":"113","author":"Parsa","year":"2010","journal-title":"J Neurosurg"},{"key":"11","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/00006123-199805000-00040","article-title":"Chemotherapy for Advanced Esthesioneuroblastoma: The Mayo Clinic Experience","volume":"42","author":"Lewis","year":"1998","journal-title":"Neurosurgery"},{"key":"12","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/0194599811416752","article-title":"Therapy and prognosis of intracranial invasive olfactory neuroblastoma","volume":"145","author":"Cai","year":"2011","journal-title":"Otolaryngol Head Neck Surg"},{"key":"13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cncr.10679","article-title":"Treatment of intracranial metastatic esthesioneuroblastoma","volume":"95","author":"Chamberlain","year":"2002","journal-title":"Cancer"},{"key":"14","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/cncr.23246","article-title":"Nonplatinum-based chemotherapy with irinotecan plus docetaxel for advanced or metastatic olfactory neuroblastoma: a retrospective analysis of 12 cases","volume":"112","author":"Ohtsu","year":"2008","journal-title":"Cancer"},{"key":"15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF01054767","article-title":"Expression of the human Achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma)","volume":"26","author":"Rothstein","year":"1995","journal-title":"J Neurooncol"},{"key":"16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/modpathol.3800038","article-title":"hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors","volume":"17","author":"Okayasu","year":"2004","journal-title":"Mod Pathol"},{"key":"17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.anndiagpath.2015.03.009","article-title":"Achaete-scute homolog 1 expression closely correlates with endocrine phenotype and degree of differentiation in sinonasal neuroendocrine tumors","volume":"19","author":"Bell","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1309\/QD0K9Q1JBH6B5GQQ","article-title":"Human achaete-scute homologue (hASH1) mRNA level as a diagnostic marker to distinguish esthesioneuroblastoma from poorly differentiated tumors arising in the sinonasal tract","volume":"122","author":"Schwaller","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"19","doi-asserted-by":"crossref","first-page":"10680","DOI":"10.1158\/0008-5472.CAN-05-1404","article-title":"ASH1 gene is a specific therapeutic target for lung cancers with neuroendocrine features","volume":"65","author":"Takahashi","year":"2005","journal-title":"Cancer Res"},{"key":"20","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1128\/MCB.22.9.3129-3139.2002","article-title":"Notch signaling induces rapid degradation of achaete-scute homolog 1","volume":"22","author":"Ball","year":"2002","journal-title":"Mol Cell Biol"},{"key":"21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ctrv.2012.04.006","article-title":"Role of angiogenesis in the pathogenesis of cancer","volume":"38","author":"Machado","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"22","first-page":"690","article-title":"Expression of SSTR2 and P-STAT3 in human olfactory neuroblastoma [Article in Chinese]","volume":"24","author":"Wu","year":"2010","journal-title":"Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11060-008-9602-9","article-title":"Expression of bcl-2 is associated with microvessel density in olfactory neuroblastoma","volume":"89","author":"St\u00f6ver","year":"2008","journal-title":"J Neurooncol"},{"key":"24","doi-asserted-by":"crossref","first-page":"14788","DOI":"10.1073\/pnas.1410419111","article-title":"ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers","volume":"111","author":"Behrens","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"25","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.otohns.2008.03.011","article-title":"Expression of Bcl-2 in olfactory neuroblastoma and its association with chemotherapy and survival","volume":"139","author":"Chung","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"key":"26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11060-009-0010-6","article-title":"Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis","volume":"97","author":"Ganten","year":"2010","journal-title":"J Neurooncol"},{"key":"27","first-page":"A303","article-title":"Expression of VEGF and bcl-2 in Olfactory Neuroblastoma: Association with Microvessel Density","volume":"19","author":"St\u00f6ver","year":"2009","journal-title":"Skull Base"},{"key":"28","first-page":"e33","article-title":"Unexpectedly durable palliation of metastatic olfactory neuroblastoma using anti-angiogenic therapy with Bevacizumab","volume":"4","author":"Bidari","year":"2012","journal-title":"Rare Tumors"},{"key":"29","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.humpath.2009.02.001","article-title":"Expression patterns of Trk-A, Trk-B, GRP78, and p75NRT in olfactory neuroblastoma","volume":"40","author":"Perez-Ordonez","year":"2009","journal-title":"Hum Pathol"},{"key":"30","doi-asserted-by":"crossref","first-page":"10299","DOI":"10.1073\/pnas.1404399111","article-title":"Neurotrophin receptor TrkB promotes lung adenocarcinoma metastasis","volume":"111","author":"Wong","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"31","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1074\/jbc.M114.599373","article-title":"Neurotrophin signalingTrkB and TrkC receptors promotes the growth of brain tumor-initiating cells","volume":"290","author":"Forsyth","year":"2015","journal-title":"J Biol Chem"},{"key":"32","doi-asserted-by":"crossref","first-page":"8067","DOI":"10.1074\/jbc.M113.513762","article-title":"p75 neurotrophin receptor cleavage by \u03b1- and \u03b3-secretases is required for neurotrophin-mediated proliferation of brain tumor-initiating cells","volume":"289","author":"Barker","year":"2014","journal-title":"J Biol Chem"},{"key":"33","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/bjc.1997.198","article-title":"Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression","volume":"75","author":"Coll","year":"1997","journal-title":"Br J Cancer"},{"key":"34","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00280-011-1581-4","article-title":"Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study","volume":"68","author":"Maris","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.canlet.2016.01.018","article-title":"Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model","volume":"372","author":"Hornby","year":"2016","journal-title":"Cancer Lett"},{"key":"36","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/humu.20495","article-title":"Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database","volume":"28","author":"Olivier","year":"2007","journal-title":"Hum Mutat"},{"key":"37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00000478-199606000-00009","article-title":"Relationship of p53 gene alterations with tumor progression and recurrence in olfactory neuroblastoma","volume":"20","author":"Finkelstein","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/1097-0142(19950701)76:1<4::AID-CNCR2820760103>3.0.CO;2-E","article-title":"Olfactory neuroblastoma. An immunohistochemical, ultrastructural, and flow cytometric study","volume":"76","author":"VandenBerg","year":"1995","journal-title":"Cancer"},{"key":"39","doi-asserted-by":"crossref","first-page":"e37029","DOI":"10.1371\/journal.pone.0037029","article-title":"Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma","volume":"7","author":"Metpally","year":"2012","journal-title":"PLoS One"},{"key":"40","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12885-016-2209-1","article-title":"Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis","volume":"16","author":"Kim","year":"2016","journal-title":"BMC Cancer"},{"key":"41","first-page":"A007","article-title":"Long-Term Outcome of Esthesioneuroblastoma: Hyams Grade Predicts Patient Survival","volume":"73","author":"Link","year":"2012","journal-title":"J Neurol Surg Part B Skull Base"},{"key":"42","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.ejca.2012.12.008","article-title":"Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome","volume":"49","author":"Bourhis","year":"2013","journal-title":"Eur J Cancer"},{"key":"43","unstructured":"Hyams, Batsakis, Michaels, U. S. AFI of P. Tumors of the upper respiratory tract and ear. 1988."},{"key":"44","first-page":"e3","article-title":"Misdiagnosis of olfactory neuroblastoma","volume":"12","author":"DeMonte","year":"2002","journal-title":"Neurosurg Focus"},{"key":"45","first-page":"51","article-title":"Prognostic Utility of Hyams Histological Grading and Kadish-Morita Staging Systems for Esthesioneuroblastoma Outcomes","volume":"9","author":"Hanna","year":"2014","journal-title":"Head Neck Pathol"},{"key":"46","first-page":"A006","article-title":"Esthesioneuroblastoma: An Update on the Massachusetts Eye and Ear Infirmary and Massachusetts General Hospital Experience with Craniofacial Resection, Proton Beam Radiation, and Chemotherapy","volume":"74","author":"Lin","year":"2013","journal-title":"J Neurol Surg Part B Skull Base"},{"key":"47","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/0003489414526368","article-title":"Esthesioneuroblastoma: updating histologic grading as it relates to prognosis","volume":"123","author":"McHugh","year":"2014","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0463.2007.apm_446.x","article-title":"Expression of human telomerase reverse transcriptase and cyclin-D1 in olfactory neuroblastoma","volume":"115","author":"Chai","year":"2007","journal-title":"APMIS"},{"key":"49","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.bjc.6690734","article-title":"Esthesioneuroblastoma is not a member of the primitive peripheral neuroectodermal tumour-Ewing's group","volume":"81","author":"Pilotti","year":"1999","journal-title":"Br J Cancer"},{"key":"50","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1750-3639.2004.tb00048.x","article-title":"CGH pattern of esthesioneuroblastoma and their metastases","volume":"14","author":"Petersen","year":"2004","journal-title":"Brain Pathol Zurich Switz"},{"key":"51","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1073\/pnas.93.3.1038","article-title":"Olfactory neuroblastoma is a peripheral primitive neuroectodermal tumor related to Ewing sarcoma","volume":"93","author":"Triche","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"52","first-page":"463","article-title":"Olfactory neuroblastoma is not a neuroblastoma but is related to primitive neuroectodermal tumor (PNET)","volume":"271","author":"Triche","year":"1988","journal-title":"Prog Clin Biol Res"},{"key":"53","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/modpathol.2008.57","article-title":"Array comparative genomic hybridization analysis of olfactory neuroblastoma","volume":"21","author":"Stelow","year":"2008","journal-title":"Mod Pathol"},{"key":"54","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0165-4608(01)00659-8","article-title":"Analysis of cytogenetic aberrations in esthesioneuroblastomas by comparative genomic hybridization","volume":"136","author":"Mann","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cancergencyto.2006.09.024","article-title":"Comprehensive cytogenetic characterization of an esthesioneuroblastoma","volume":"173","author":"Ahnert","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"56","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/BF01411401","article-title":"Olfactory neuroblastoma: Detection of genomic imbalances by comparative genomic hybridization","volume":"139","author":"Petersen","year":"1997","journal-title":"Acta Neurochir (Wien)"},{"key":"57","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/gcc.22288","article-title":"Comparative genomic hybridization on microarray (a-CGH) in olfactory neuroblastoma: Analysis of ten cases and review of the literature","volume":"54","author":"Maserati","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13008-015-0009-7","article-title":"Aneuploidy and chromosomal instability in cancer: a jackpot to chaos","volume":"10","author":"Rancati","year":"2015","journal-title":"Cell Div"},{"key":"59","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cell.2011.01.017","article-title":"Identification of aneuploidy-selective antiproliferation compounds","volume":"144","author":"Amon","year":"2011","journal-title":"Cell"},{"key":"60","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.4161\/cc.8.20.9690","article-title":"Chromosomal instability: a composite phenotype that influences sensitivity to chemotherapy","volume":"8","author":"Swanton","year":"2009","journal-title":"Cell Cycle"},{"key":"61","first-page":"333","article-title":"Amplification of zinc finger gene 217 (ZNF217) and cancer: when good fingers go bad","volume":"1775","author":"Crossley","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"62","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1002\/cncr.26598","article-title":"Prognostic and therapeutic impact of the chromosome 20q13. 2 ZNF217 locus amplification in ovarian clear cell carcinoma","volume":"118","author":"Miyazaki","year":"2012","journal-title":"Cancer"},{"key":"63","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.oraloncology.2015.01.014","article-title":"Combined TP53 mutation\/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma","volume":"51","author":"Tsien","year":"2015","journal-title":"Oral Oncol"},{"key":"64","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/gcc.22214","article-title":"Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease","volume":"53","author":"Gollin","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"65","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/pbc.22816","article-title":"Determination of 17q gain in patients with neuroblastoma by analysis of circulating DNA","volume":"56","author":"Puisieux","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"66","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1101\/gad.1286905","article-title":"mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival","volume":"19","author":"Depinho","year":"2005","journal-title":"Genes Dev"},{"key":"67","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.onc.1208201","article-title":"Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis","volume":"24","author":"Swarup","year":"2005","journal-title":"Oncogene"},{"key":"68","doi-asserted-by":"crossref","first-page":"e3536","DOI":"10.1097\/MD.0000000000003536","article-title":"Recurrent Olfactory Neuroblastoma Treated With Cetuximab and Sunitinib: A Case Report","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"69","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.1158\/1078-0432.CCR-12-0827","article-title":"Genetically defined subsets of human pancreatic cancer show uniquechemosensitivity","volume":"18","author":"Eshleman","year":"2012","journal-title":"Clin Cancer Res"},{"key":"70","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.4161\/cc.10.12.16008","article-title":"Inflammasome-mediated suppression of inflammation-induced colorectal cancer progression is mediated by direct regulation of epithelial cell proliferation","volume":"10","author":"Flavell","year":"2011","journal-title":"Cell Cycle"},{"key":"71","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1101\/gad.181685.111","article-title":"Mutant p53 cooperates with ETS2 to promote etoposide resistance","volume":"26","author":"Martinez","year":"2012","journal-title":"Genes Dev"},{"key":"72","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11060-009-0027-x","article-title":"Disease stabilization of progressive olfactory neuroblastoma (esthesioneuroblastoma) under treatment with sunitinib mesylate","volume":"97","author":"Marosi","year":"2010","journal-title":"J Neurooncol"},{"key":"73","first-page":"29","article-title":"Imatinib mesylate as second-line treatment in a c-kit-positive esthesioneuroblastoma","author":"Ottmann","year":"2011","journal-title":"J Clin Oncol"},{"key":"74","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/B:NEON.0000040826.30636.4a","article-title":"Intracranial metastatic esthesioneuroblastoma responsive to temozolomide","volume":"70","author":"Weller","year":"2004","journal-title":"J Neurooncol"},{"key":"75","first-page":"6","article-title":"Paraneoplastic syndromes in olfactory neuroblastoma","volume":"19","author":"Sworczak","year":"2015","journal-title":"Contemp Oncol (Poznan\u0144, Poland)"},{"key":"76","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s11060-016-2067-3","article-title":"Somatostatin receptors imaging and therapy in a patient affected by esthesioneuroblastoma with meningeal metastases. A classic example of theranostic approach","volume":"127","author":"Bignardi","year":"2016","journal-title":"J Neurooncol"},{"key":"77","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/BF03347351","article-title":"Is there a therapeutic role for octreotide in patients with ectopic Cushing's syndrome?","volume":"26","author":"Pacak","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"78","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000236047","article-title":"Activation of sonic hedgehog signaling pathway in olfactory neuroblastoma","volume":"77","author":"Hu","year":"2009","journal-title":"Oncology"},{"key":"79","article-title":"Novel targeted treatment combinations for malignant neuroendocrine tumour olfactory neuroblastoma","author":"Korbonits","year":"2015","journal-title":"Endocr Abstr"},{"key":"80","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11523-011-0167-8","article-title":"Mechanisms of mTOR inhibitor resistance in cancer therapy","volume":"6","author":"Nawrocki","year":"2011","journal-title":"Target Oncol"},{"key":"81","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","article-title":"Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance","volume":"1773","author":"Libra","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"82","first-page":"1253","article-title":"Fibroblast growth factor receptor-1 as a potential therapeutic target in sinonasal cancer","volume":"36","author":"Lengerke","year":"2014","journal-title":"Head Neck"},{"key":"83","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1006\/bbrc.2000.3899","article-title":"bFGF Induces Differentiation and Death of Olfactory Neuroblastoma Cells","volume":"279","author":"Rothstein","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"84","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s004410050030","article-title":"Olfactory epithelium consisting of supporting cells and horizontal basal cells in the posterior nasal cavity of mice","volume":"299","author":"Takeichi","year":"2000","journal-title":"Cell Tissue Res"},{"key":"85","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2990.2002.00397.x","article-title":"Co-expression of trkA and p75 neurotrophin receptor in extracranial olfactory neuroblastoma cells","volume":"28","author":"Zhou","year":"2002","journal-title":"Neuropathol Appl Neurobiol"},{"key":"86","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0306-4522(96)00143-1","article-title":"Induction of differentiation of human olfactory neuroblastoma cells into odorant-responsive cells","volume":"74","author":"Rothstein","year":"1996","journal-title":"Neuroscience"},{"key":"87","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1158\/2159-8290.CD-12-0093","article-title":"The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression","volume":"2","author":"Sternlicht","year":"2012","journal-title":"Cancer Discov"},{"key":"88","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1093\/hmg\/ddi352","article-title":"ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction","volume":"14","author":"Collins","year":"2005","journal-title":"Hum Mol Genet"},{"key":"89","first-page":"E2259","article-title":"Neuroendocrine neoplasms of the sinonasal region","volume":"38","author":"Rodrigo","year":"2015","journal-title":"Head Neck"},{"key":"90","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/era.13.1","article-title":"Sinonasal undifferentiated carcinoma: morphological heterogeneity, diagnosis, management and biological markers","volume":"13","author":"Hanna","year":"2013","journal-title":"Expert Rev Anticancer Ther"},{"key":"91","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00405-013-2554-5","article-title":"The importance of multimodality therapy in the treatment of sinonasal neuroendocrine carcinoma","volume":"270","author":"Halmos","year":"2013","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"92","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1002\/cncr.20693","article-title":"Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype","volume":"101","author":"Chao","year":"2004","journal-title":"Cancer"},{"key":"93","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jocn.2012.05.029","article-title":"The prognostic implications of Hyam's subtype for patients with Kadish stage C esthesioneuroblastoma","volume":"20","author":"Parsa","year":"2013","journal-title":"J Clin Neurosci"},{"key":"94","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/PAS.0000000000000580","article-title":"Large Cell Neuroendocrine Carcinoma of the Head and Neck: A Clinicopathologic Series of 10 Cases With an Emphasis on HPV Status","volume":"40","author":"Bishop","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"95","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/PAS.0b013e31823f2f17","article-title":"HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior","volume":"36","author":"Krane","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"96","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/PAS.0b013e3182698673","article-title":"Human papillomavirus-related carcinomas of the sinonasal tract","volume":"37","author":"Westra","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"97","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hed.23606","article-title":"Treatment outcomes and prognostic factors, including human papillomavirus, for sinonasal undifferentiated carcinoma: a retrospective review","volume":"37","author":"Lin","year":"2015","journal-title":"Head Neck"},{"key":"98","first-page":"94","article-title":"Incidence and survival patterns of sinonasal undifferentiated carcinoma in the United States","volume":"76","author":"Lin","year":"2015","journal-title":"J Neurol Surg B Skull Base"},{"key":"99","article-title":"Sinonasal small cell neuroendocrine carcinoma: a systematic review of 80 patients","author":"Liang","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"100","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/alr.21497","article-title":"Sinonasal neuroendocrine carcinoma: a population-based analysis of incidence and survival","volume":"5","author":"Eloy","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"key":"101","doi-asserted-by":"crossref","first-page":"e006440","DOI":"10.1136\/bmjopen-2014-006440","article-title":"Patterns of relapse in extrapulmonary small cell carcinoma: retrospective analysis of outcomes from two cancer centres","volume":"5","author":"Popat","year":"2015","journal-title":"BMJ Open"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9683","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T05:40:37Z","timestamp":1589262037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,31]]},"references-count":101,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2016,8,9]]}},"alternative-id":["9683","27256979"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.9683","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,31]]}}}